Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Internal Medicine Alert

RSS  

Articles

  • Stress Reduction for Physicians — What Works?

    A randomized controlled study of 129 physicians demonstrated that a two-month regimen of sudarshan kriya yoga, incorporating stretching, breathing, and meditation, is associated with reduced stress, anxiety, and depressive symptoms when compared to conventional stress management training.

  • Does Calcium Intake Cause Cardiovascular Disease?

    A large population study of calcium intake at dinner vs. breakfast showed an increased risk of heart disease.

  • Ceftobiprole Medocaril Sodium for Injection (Zevtera)

    The U.S. Food and Drug Administration has approved a new cephalosporin antibacterial for the treatment of three serious infections: bloodstream, skin and skin structure, and community-acquired pneumonia. Ceftobiprole is a fifth-generation cephalosporin with in vitro activity against gram-positive and gram-negative bacteria including multidrug resistant organisms. It will be distributed by Basilea Pharmaceutica International Ltd, Allschwil as Zevtera.

  • Another Step in the Journey to Combat Diagnostic Errors in Hospitalized Patients

    Diagnostic errors in hospitalized patients who died or were transferred to the intensive care unit were common in this large retrospective, multicenter trial and frequently associated with patient harm. Problems with clinical assessment and ordering and interpreting tests were the most prevalent diagnostic process faults, with sepsis the diagnosis most associated with diagnostic error.

  • Increased Risk of Morbidity with Prolonged Use of PPIs Without an Indication Post-ICU

    In previously critically ill adults, the use of a proton pump inhibitor without an indication for more than eight weeks increased morbidity and mortality.

  • The Burden of Clostridioides difficile Infection

    This article outlines the clinical, social, and economic burden of Clostridioides difficile infection (CDI) in the United States and its shifting epidemiology.

  • Inappropriate Diagnosis of Pneumonia Is Common in Hospitalized Patients

    A cohort study that included 48 hospitals in Michigan found that 12% of patients treated for community-acquired pneumonia were diagnosed inappropriately. Older age, dementia, and presenting with acute change in mental status increased the risk for misdiagnosis.

  • Which Is the Key Lead?

    The patient whose ECG appears in the figure is a middle-aged man who presented to the emergency department with new chest pain. Should the cath lab be activated?

  • Cefepime and Enmetazobactam Injection (Exblifep)

    The U.S. Food and Drug Administration has approved the combination of cefepime and enmetazobactam (FPE) for the treatment of complicated urinary tract infections. Cefepime-enmetazobactam was granted a priority review and a five-year marketing exclusivity as part of the Generating Antibiotic Incentive Now (GAIN) Act incentivizing development of new anti-infectives. FPE is distributed by Allecra Therapeutics SAS as Exblifep.

  • Comparing Early vs. Late-Onset MS

    A recent retrospective study, combining data from a United Kingdom patient registry with a United Kingdom neuropathology tissue bank, showed that late-onset multiple sclerosis (MS), referring to disease onset after age 50 years, is linked with increased disability and quicker progression compared to MS onset at a younger age, and has distinct pathological features.